Third -Quarter 2025 Earnings Baxter International Inc. October 30, 2025 1 Forward-Looking Statements This presentation includes forward-looking statements concerning the company's financial results (including the outlook for fourth-quarter and full-year 2025) and operational, business development and regulatory activities. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the fo ...

Financial Performance Highlights - ICE achieved record 3Q25 net revenues of $2411 million, a 2% increase compared to $2349 million in 3Q24[6] - Recurring revenues reached $1275 million, representing a 5% increase[6] - Adjusted diluted EPS increased by 10% to $171[6] - Adjusted free cash flow year-to-date reached $3178 million, a 21% increase[6] Segment Performance - Exchanges segment net revenues totaled $1265 million, a 1% increase[9] - Fixed Income & Data Services revenues increased by 5% to $618 million[12] - Mortgage Technology segment revenues grew by 4% to $528 million[15] Key Growth Drivers - Data & connectivity services revenues within the Exchanges segment increased by 9%[9] - Data & network technology revenues within Fixed Income & Data Services grew by 10%[13] - Transaction revenues in Mortgage Technology increased by 12%[17] Capital Management - $674 million was returned to stockholders in 3Q25, including ~$400 million in share repurchases[8] - Ending 3Q25 leverage was approximately 29x[8] 2025 Guidance - FY25 adjusted expenses are expected to be between $3933 billion and $3943 billion[24]

Financial Performance - Q3 2025 - Consolidated revenue increased by 9% year-over-year, from $288417 thousand in Q3 2024 to $315443 thousand in Q3 2025[22] - Consolidated Adjusted EBITDA also increased by 9% year-over-year, from $170376 thousand to $186317 thousand[22] - Fire Safety revenue increased by 9% year-over-year, from $251845 thousand to $273384 thousand, with Adjusted EBITDA increasing by 13% from $157479 thousand to $177210 thousand[22] - Specialty Products revenue increased by 15% year-over-year, from $36572 thousand to $42059 thousand, but Adjusted EBITDA decreased by 29% from $12897 thousand to $9107 thousand[22] Financial Performance - Year-to-Date (YTD) 2025 - Consolidated revenue increased by 16% year-over-year, from $474737 thousand to $550112 thousand[22] - Consolidated Adjusted EBITDA increased by 20% year-over-year, from $247420 thousand to $295738 thousand[22] - Fire Safety revenue increased by 15% year-over-year, from $375538 thousand to $430831 thousand, with Adjusted EBITDA increasing by 24% from $212877 thousand to $264954 thousand[22] - Specialty Products revenue increased by 20% year-over-year, from $99199 thousand to $119281 thousand, but Adjusted EBITDA decreased by 11% from $34543 thousand to $30784 thousand[22] Capital Structure and Allocation - The company has approximately 1479 million basic shares outstanding[28] - Net debt to LTM Adjusted EBITDA is 10, with net debt at $334353 thousand and LTM Adjusted EBITDA at $328612 thousand[40] - Cash and cash equivalents totaled $3406 million as of Q3 2025[29]

Portfolio Overview - LXP Industrial Trust has gross assets of $4.8 billion and owns 112 properties [7] - The stabilized portfolio is 96.8% leased [12, 17] - 48% of the tenancy is investment grade [9] - The portfolio's weighted average lease term (WALT) is 4.9 years [17] Financial Performance - The company generated Adjusted Company FFO of $0.16 per share in the third quarter [12] - Same-store NOI growth was 4% year-to-date and 2% in the quarter [12] - The company repaid $140 million of outstanding 6.75% Senior Notes due 2028 [12] - Net Debt to Adjusted EBITDA was reduced to 5.2x [12, 13] Growth Opportunities - Approximately 64% of the portfolio is expiring through 2030, with current mark-to-market on rents estimated to be approximately 17% [15, 64] - The average annual rental escalations are 2.9% [15, 60] - The company has 1.8 million square feet of first and second-generation space available for lease [15, 60] Strategic Initiatives - The company sold two vacant development projects totaling 2.1 million square feet for $175 million, representing a 20% premium over the gross book value [12] - The company acquired one property for $30 million at a cash capitalization rate of 6.5% [12] - The company announced a reverse stock split of common shares at a ratio of 1-for-5 [12]

Financial Performance - Total net product revenues reached $851 million in Q3 2025, representing a 103% year-over-year growth compared to Q3 2024[17, 24] - Total TTR net revenues were $724 million in Q3 2025, a 135% increase year-over-year[17, 31] - U S total TTR net revenues amounted to $543 million in Q3 2025, demonstrating a 194% year-over-year growth[17] - The company increased its 2025 total net product revenue guidance to a range of $2950 million to $3050 million, a 10% increase at the midpoint[17] - Non-GAAP operating income was $476 million, resulting in a 38% non-GAAP operating margin[65] Product Performance - Rare disease franchise revenues totaled $127 million in Q3 2025, a 14% increase year-over-year[28] - OXLUMO sales grew by 31% year-over-year, driven by a 15% increase in global patients on therapy[29] - AMVUTTRA's ATTR-CM launch contributed significantly to growth, with estimated ATTR-CM revenue of approximately $300 million in Q3 2025 in the U S [33, 34] Pipeline and Clinical Development - Phase 3 trial initiated for nucresiran in ATTR-CM, with topline results expected in 2028 and targeting launch around 2030[17, 47] - Phase 3 cardiovascular outcomes trial (CVOT) initiated for zilebesiran in high cardiovascular risk patients with uncontrolled hypertension, randomizing approximately 11,000 patients[17, 56] - HELIOS-B data showed a 37% risk reduction in time-to-first ACM and CV events with long-term vutrisiran treatment[43]

Company Strategy & Vision - Omnicell's growth strategy focuses on connecting the health network, disrupting pharmacy care with innovation, and growing where care is delivered[12] - The company aims to transform pharmacy care through outcomes-centric solutions, combining robotics, software, expert services, and analytics[13] - Omnicell is executing on its goal to advance the industry-defined vision of the Autonomous Pharmacy[30] Financial Performance & Metrics - Q3 2025 total revenues reached $311 million, a 10% year-over-year increase[71] - Non-GAAP gross margin for Q3 2025 was 442%, a decrease of 30 basis points year-over-year[71] - Non-GAAP operating expenses for Q3 2025 were $110 million, a 9% increase year-over-year[71] - Non-GAAP EBITDA for Q3 2025 was $41 million, a 6% increase year-over-year[71] - Non-GAAP diluted earnings per share for Q3 2025 were $051, a decrease of $005 year-over-year[71] - The company projects total year 2025 revenue between $1177 billion and $1187 billion, a 6% year-over-year change at the midpoint[72] - The company projects product bookings between $500 million and $550 million for TY-2025[78] - The company projects annual recurring revenue (ARR) between $610 million and $630 million for TY-2025[78] Recurring Revenue & SaaS - SaaS and Expert Services are projected to be 22% of total revenue in 2025[9, 27]

Financial Performance Highlights - Net sales reached $1 billion, a 13% year-over-year increase[11] - Net income was $62 million, representing 6% of net sales, a 75% year-over-year increase[11] - Adjusted EBITDA was $106 million, or 10.2% of net sales, a 24% year-over-year increase[11] - The company returned $215 million of capital to shareholders through dividends and strategic share buybacks year-to-date through Q3[12,50] Operational Performance and Market Trends - North American wholesale towable unit shipments were 65,700 in Q3 2025, a 4% year-over-year decrease[18] - North American retail towable units sold were estimated at 88,900 in Q3 2025, a 1% year-over-year increase[18] - Q3 2025 RV OEM sales increased by 11% year-over-year, driven by price increases related to tariffs, increased mix in higher-content fifth wheels, market share gains, and an increase in North American motorhome RV unit shipments[18] - Adjacent Industries sales increased by 22% year-over-year, primarily due to recent acquisitions in the resilient bus market and higher sales to North American utility trailer and marine OEMs[27] - Aftermarket sales increased by 7% year-over-year, driven by product innovations and the expanding Camping World relationship within the RV aftermarket[32] Strategic Initiatives and Outlook - The company projects approximately $380 million in consolidated net sales for October 2025, a 15% year-over-year increase[57] - The company is targeting 8 to 10 facility consolidations in 2026 after 5 in 2025[63] - The company is exploring divestiture opportunities in 2026 of approximately $75 million of revenues that are dilutive to the business[63]

Financial Performance - Net revenue increased by 80% compared to the prior year, or 44% on a constant currency basis[15] - Global sales of automation equipment increased by 630% compared to the prior year, or 562% on a constant currency basis[15] - Adjusted EBITDA increased by 81% (35% on a constant currency basis), including a 400 bps non-cash headwind for the provision of warrants in revenue ($08 million)[15] - Gross margin decreased by 28% year-over-year to 345% (344% on a constant currency basis) due to increased production costs and product mix[15] - Year-to-date net revenue increased by 56% on a constant currency basis[29] - Year-to-date Adjusted EBITDA decreased by 78% on a constant currency basis[29] Regional Performance - North America revenue increased by 109% due to increased volumes from e-commerce activity among large enterprise accounts[15] - EMEA/APAC revenue increased by 58% (decreased 06% on a constant currency basis) driven by increased automation equipment sales and stronger Euro to USD exchange rates[15] - Volumes in Europe/APAC were down by 25% due to a challenging environment and uncertainty from tariffs and de-stocking in APAC[17] Strategic Agreements - Agreement with Walmart is anticipated to be transformative to Automation and implies, based on expectations and current paper pricing, potential spend of $700 million over 10 years, to achieve full vesting[22] - Potential spend for maximum vesting with Amazon is $400 million excluding the cost of paper related to pre-existing NOAM business lines[32]

Q3 2025 Results - Revenue reached $1.4 billion, a 48% year-over-year growth[5] - Bookings totaled $1.9 billion, showing a 70% year-over-year increase[5] - Average Daily Active Users (DAUs) were 151.5 million, up 70% year-over-year[5] - Hours Engaged reached 39.6 billion, a significant 91% year-over-year growth[5] - Net loss was $(257) million, a 121% year-over-year growth[7] - Net cash provided by operating activities was $546 million[7] - Free cash flow was $443 million, a 103% year-over-year growth[7] - Adjusted EBITDA was $46 million[7] Q4 and Fiscal Year 2025 Guidance - Q4 2025 revenue is projected between $1.35 billion and $1.4 billion, representing a 37% to 42% year-over-year increase[57] - Q4 2025 bookings are expected to be between $2 billion and $2.05 billion, a 47% to 51% year-over-year increase[57] - Fiscal year 2025 revenue is guided between $4.8255 billion and $4.8755 billion, a 34% to 35% year-over-year increase[58] - Fiscal year 2025 bookings are projected between $6.5662 billion and $6.6162 billion, a 50% to 51% year-over-year increase[58]

Portfolio & Investment - Total portfolio investments stand at approximately $6.9 billion[11], spread across 330 properties[11] - Experiential portfolio accounts for roughly $6.5 billion, representing 94% of total investments[12] - Q3 investment spending reached $54.5 million[11], bringing the year-to-date total to $140.8 million[29] - The company anticipates disposition proceeds between $150 million and $160 million for 2025[33] Financial Performance - Total revenue for Q3 2025 was $182.3 million, a 1% increase compared to $180.5 million in Q3 2024[41] - Net income attributable to common shareholders for Q3 2025 increased by 49.3% to $60.6 million, compared to $40.6 million in Q3 2024[41] - For the nine months ended September 30, 2025, total revenue was $535.4 million, a 2.8% increase from $520.8 million in the same period of 2024[44] - Net income attributable to common shareholders for the nine months ended September 30, 2025, increased by 39.2% to $189.9 million, compared to $136.4 million in the same period of 2024[44] Guidance - The company revised its FFO as adjusted per share guidance to $5.05-$5.13[53] - Investment spending guidance remains between $225 million and $275 million[53]